In short
Psoriasis is an autoimmune condition characterised by accelerated skin cell turnover, producing the characteristic raised, scaly plaques that appear on the skin surface. At CLCC, care for psoriasis follows a five-step structured assessment: Assess, Identify, Reduce, Restore, Continue, addressing the systemic contributors alongside standard medical treatment, rather than symptom management alone.
What Is Psoriasis
Psoriasis is showing on the skin what is happening deeper in the body.
Psoriasis is an autoimmune condition characterised by accelerated skin cell turnover, producing the characteristic raised, scaly plaques that appear on the skin surface. The underlying mechanism is immune overactivation: T-cells mistakenly attack skin cells, signalling the skin to produce new cells far faster than they can be shed. The result is the visible accumulation of immature skin cells that characterises psoriatic plaques.
What drives this immune overactivation is not simply a skin problem. The gut-immune connection is central and well-documented in psoriasis research: gut barrier dysfunction allows bacterial endotoxins into the bloodstream that directly activate the inflammatory immune pathways responsible for psoriatic skin activity. Gut microbiome composition in psoriasis patients is notably different from healthy controls, and gut restoration helps improve skin outcomes.
Systemic inflammation from dietary patterns, nutritional deficiencies in vitamin D and zinc that are critical for immune regulation, stress-load that directly activates inflammatory pathways, and metabolic dysfunction that elevates inflammatory markers, all sustain the immune environment that produces psoriatic flares. Treating only the skin produces remission without addressing what caused the flare. CLCC addresses what caused it.
CLCC care runs alongside dermatology management, not as a replacement. The systemic approach addresses what topical and biological treatments cannot: the gut, nutritional, and lifestyle drivers that sustain the immune overactivation between treatments.
Symptoms
What psoriasis typically feels like.
Raised, red, inflamed patches covered with silvery-white scales, most commonly on elbows, knees, scalp, and lower back
Dry skin that may crack and bleed
Intense itching, burning, or soreness around the plaques
Thickened, pitted, or ridged nails, nail psoriasis
Cyclical flares, periods of worsening followed by partial improvement
Flares reliably triggered by stress, infections, certain medications, or dietary patterns
Scalp involvement producing scaling and itching that extends beyond the hairline
Joint pain and swelling in patients who also have psoriatic arthritis
Emotional distress from the visible nature of the condition, significantly affecting social confidence
Burning or soreness in skin folds, inverse psoriasis in some patients
Potential Contributing Factors
Psoriasis is driven by more than one system.
Understanding which factors are most active in your case is the purpose of the CLCC assessment. Each of the following can sustain immune dysregulation independently.
Gut barrier dysfunction
Increased intestinal permeability allows bacterial lipopolysaccharides into the bloodstream, directly activating the Th17 immune pathway that drives psoriatic skin inflammation. Gut barrier repair is a primary psoriasis intervention, not a peripheral consideration.
Gut microbiome disruption
Psoriasis patients show reduced microbiome diversity and altered bacterial composition compared to controls. Specific bacterial species, including reduced Faecalibacterium prausnitzii, are associated with worse psoriatic activity. Microbiome restoration improves skin outcomes.
Vitamin D deficiency
Vitamin D is a key immune regulator, suppressing the Th1 and Th17 immune pathways that drive psoriatic inflammation. Deficiency, which is extremely common in psoriasis patients, removes a critical brake on the overactive immune response. Therapeutic vitamin D correction is a direct immune intervention.
Zinc deficiency
Zinc is essential for skin barrier function, wound healing, and immune regulation. Psoriasis patients show lower zinc levels than controls. Zinc deficiency sustains both the skin barrier dysfunction and the immune dysregulation that drive psoriatic activity.
Systemic inflammation
Elevated TNF-alpha, IL-17, and IL-23, the cytokines targeted by biological psoriasis medications, are sustained by dietary patterns, gut dysfunction, and metabolic factors. Reducing the systemic inflammatory environment lowers the baseline cytokine levels that trigger flares.
Stress-load
Psychological stress directly activates the HPA axis and sympathetic nervous system, producing cytokines that trigger psoriatic flares independently of other factors. Sustained stress load maintains the inflammatory environment between flares and reduces the flare threshold.
Impact on Daily Life
How psoriasis changes daily life.
→Profound social and psychological impact, visible skin condition affecting confidence, relationships, and professional life
→Sleep disruption from itching and discomfort, compounding fatigue and reducing immune resilience
→Restriction of clothing choices, swimming, physical intimacy, and social situations
→Cumulative medication burden, topical steroids, immunosuppressants, biologicals, each with significant side effect profiles requiring management
→Joint involvement in psoriatic arthritis complicating physical function and pain management
→Cardiovascular risk elevation, psoriasis is independently associated with higher cardiovascular risk through shared inflammatory pathways
→Metabolic association, psoriasis patients have significantly higher rates of insulin resistance, obesity, and metabolic syndrome
The CLCC Method: Five Steps Applied
Each step separate. Each specific to your immune and systemic profile.
Full systemic and immunological assessment
Gut health indicators, barrier integrity and microbiome markers. Nutritional status, vitamin D, zinc, omega-3. Inflammatory markers. Metabolic profile. Stress-load evaluation. Detailed trigger pattern from patient history. Dermatology history and treatment response reviewed.
Map which contributors are most dominant in your specific case
Gut-dominant psoriasis (strong diet-flare correlation) vs stress-dominant (flares reliably stress-triggered) vs nutritional-dominant (severe deficiency pattern) have different care plan priorities. The assessment makes this differentiation explicitly.
Coordinated gut, nutritional, and anti-inflammatory correction
Gut barrier repair protocol. Microbiome restoration targeting psoriasis-relevant bacterial strains. Therapeutic vitamin D3 and zinc supplementation. Anti-inflammatory dietary protocol, omega-3 rich, low refined carbohydrate, Mediterranean pattern. Stress-load reduction programme. All simultaneously.
Track PASI score, trigger frequency, and gut health markers at intervals
Psoriasis Area and Severity Index (PASI) tracked alongside gut health indicators and nutritional markers. Dietary trigger avoidance reviewed. Protocol refined based on measured flare reduction and skin clearance rate.
Long-term immune regulation maintenance
Psoriasis recurs when the gut environment, nutritional status, and inflammatory load reload. The Continue phase monitors these indicators with periodic review, maintaining the systemic environment that prevents flare recurrence and adjusting support as seasons, stress, and life circumstances change.
Frequently Asked Questions
Questions patients ask about psoriasis care.
Can psoriasis be cured?+
There is no permanent cure for psoriasis, the genetic predisposition remains. What structured systemic care is designed to achieve is prolonged remission, reduced flare frequency and severity, and in many patients sustained skin clearance. The critical difference from symptomatic management is that addressing the gut, nutritional, and inflammatory drivers produces more durable remission than topical or biological suppression alone.
Should I stop my dermatology treatment to start CLCC care?+
No. CLCC care runs alongside existing dermatology treatment, not as a replacement. Biological medications, topical treatments, and phototherapy each have a role. CLCC addresses the systemic environment that sustains the immune overactivation between and during treatments, which typically produces better overall outcomes than either approach alone.
Is diet important in psoriasis?+
Dietary patterns are among the most clinically significant modifiable contributors to psoriatic activity. Gluten sensitivity (even without coeliac disease) is reported by a significant proportion of psoriasis patients as a flare trigger. The Mediterranean dietary pattern helps reduce psoriatic severity in clinical studies. Specific food triggers differ between patients, identifying them through structured assessment is more useful than generic dietary advice.
Is psoriasis related to stress?+
Yes, directly. Stress-induced psoriatic flares are among the most commonly reported patterns. This pathway is not psychological but physiological: stress hormones activate the same cytokine pathways that drive psoriatic inflammation. Patients with high stress load tend to have more frequent flares, higher baseline inflammatory markers, and poorer treatment response. Stress management is a clinical psoriasis intervention.
What is the connection between psoriasis and gut health?+
The gut-skin axis is one of the most well documented findings in psoriasis research. Psoriasis patients show reduced gut microbiome diversity, altered bacterial composition, and evidence of increased gut permeability compared to healthy controls. Gut-derived endotoxins that enter the bloodstream through a disrupted gut barrier directly activate the inflammatory pathways responsible for psoriatic skin activity. Gut restoration helps improve skin outcomes, independently of changes to topical or systemic treatment.